People: Infant Bacterial Therapeutics AB (IBTb.ST)
Mr. Eamonn Connolly, Ph.D. serves as Head of Research & Development at Infant Bacterial Therapeutics AB. Eamonn is the former VP Research of BioGaia, with 15 years experience working with pre-clinical and clinical research on live bacterial therapies. He has earlier experience from the pharmaceutical industry including leading positions in R&D at Kabi Vitrum, Pharmacia & Upjohn and Fresenius Kabi.
|Total Annual Compensation,||--|
|Restricted Stock Award,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|